154
edits
No edit summary |
mNo edit summary |
||
| (16 intermediate revisions by the same user not shown) | |||
| Line 1,086: | Line 1,086: | ||
| | | | ||
|} | |} | ||
{| class="wikitable" | {| class="wikitable" | ||
|'''BLODD GASES''' | |'''BLODD GASES''' | ||
| Line 1,200: | Line 1,202: | ||
|'''mmol/L''' | |'''mmol/L''' | ||
| | | | ||
| | |- | ||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
|'''CORD GASES''' | |'''CORD GASES''' | ||
|'''ARTERIAL''' | |'''ARTERIAL''' | ||
| Line 1,244: | Line 1,251: | ||
| | | | ||
|} | |} | ||
{| class="wikitable" | {| class="wikitable" | ||
|'''Urine''' | |'''Urine''' | ||
| Line 1,352: | Line 1,361: | ||
|'''mmol/24hrs''' | |'''mmol/24hrs''' | ||
|'''diet dependent''' | |'''diet dependent''' | ||
|- | |||
|'''U Protein (24hrs)''' | |||
| | |||
|'''0.0-0.14''' | |||
|'''g/24hrs''' | |||
| | |||
|- | |- | ||
|'''U Pro/Crn Ratio''' | |'''U Pro/Crn Ratio''' | ||
| Line 1,359: | Line 1,374: | ||
| | | | ||
|- | |- | ||
|''' | |'''U Sodium (24hrs)''' | ||
| | |||
|'''100-250''' | |||
|'''mmol/24hrs''' | |||
|'''diet dependent''' | |||
|- | |||
|'''U Urea (24hrs)''' | |||
| | |||
|'''165-580''' | |||
|'''mmol/24hrs''' | |||
| | |||
|} | |||
{| class="wikitable" | |||
|'''LIPIDS''' | |||
|'''SEX/AGE''' | |||
|'''REF RANGE''' | |||
|'''UNITS''' | |||
|'''COMMENTS''' | |||
|- | |||
|'''Cholesterol (Total)''' | |||
| | |||
|'''<4.0''' | |||
|'''mmol/L''' | |||
| | |||
|- | |||
|'''HDL Cholesterol''' | |||
| | |||
|'''>1.0''' | |||
|'''mmol/L''' | |||
| | |||
|- | |||
|'''LDL (calculated)''' | |||
| | |||
|'''<2.5''' | |||
|'''mmol/L''' | |||
| | |||
|- | |||
|'''Chol/HDL Ratio''' | |||
| | |||
|'''<4.5''' | |||
| | |||
| | |||
|- | |||
|'''Triglyceride''' | |||
| | |||
|'''<1.7''' | |||
|'''mmol/L''' | |||
| | |||
|} | |||
'''Optimal lipid levels are suggested by the New Zealand Guidelines Group.''' | |||
'''http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012''' | |||
{| class="wikitable" | |||
|'''DRUGS''' | |||
| | |||
|'''REF RANGE''' | |||
|'''UNITS''' | |||
|'''COMMENTS''' | |||
|- | |||
|'''Carbamazepine''' | |||
|'''Therapeutic range''' | |||
|'''16-50''' | |||
|'''umol/L''' | |||
| | |||
|- | |||
|'''Digoxin''' | |||
|'''Therapeutic range''' | |||
|'''0.6-2.0''' | |||
|'''nmol/L''' | |||
|'''>6 hrs post-dose''' | |||
|- | |||
|'''Ethanol''' | |||
|'''Nil detected''' | |||
|'''<2.2''' | |||
|'''mmol/L''' | |||
| | |||
|- | |||
|'''Lithium''' | |||
|'''for prophylaxis''' | |||
|'''0.4-0.8''' | |||
|'''mmol/L''' | |||
| | |||
|- | |||
| | |||
|'''for acute mania''' | |||
|'''0.8-1.2''' | |||
|'''mmol/L''' | |||
| | |||
|- | |||
| | |||
|'''toxicity is common''' | |||
|'''>1.2''' | |||
|'''mmol/L''' | |||
|'''>12 hrs post-dose''' | |||
|- | |||
|'''Phenytoin''' | |||
|'''Therapeutic range''' | |||
|'''40-80''' | |||
|'''umol/L''' | |||
| | |||
|- | |||
|'''Salicylate''' | |||
|'''Therapeutic range''' | |||
|'''1.5-1.8''' | |||
|'''mmol/L''' | |||
| | |||
|- | |||
| | |||
|'''Toxic''' | |||
|'''>3.6''' | |||
|'''mmol/L''' | |||
| | |||
|- | |||
|'''Theophylline''' | |||
|'''Therapeutic range''' | |||
|'''55-110''' | |||
|'''umol/L''' | |||
| | | | ||
|- | |||
|'''Valproate''' | |||
|'''<6 months''' | |||
|'''28-55''' | |||
|'''umol/L''' | |||
| | | | ||
|- | |||
| | | | ||
| | |'''>6 months''' | ||
|'''350-700''' | |||
|'''umol/L''' | |||
|'''not reported but widely accepted as a trough range''' | |||
|} | |} | ||
'''Note: Antibiotics - Gentamicin, Vancomycin and Tobramycin ranges, please refer to Pharmacy for dose and time related reference ranges.''' | |||
'''Reference ranges have been set in agreeance with:''' | |||
'''- The South Island Quality Assurance Group (SIQAG)''' | |||
'''- Chemical Pathology Network New Zealand (CHEMPNNZ)''' | |||
'''- Te Whatu Ora Hawkes Bay Chemical Pathologist''' | |||
'''- Abbott Alinity assay specific reference ranges''' | |||
''' - The LabNet Delphic Partners''' | |||
'''Reference ranges reviewed August 2023''' | |||